ArticleDrugs in context2024

Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study.

Jesús Calleja-Escudero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.